Last updated on June 2019

TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis


Brief description of study

The purpose of this study is to assess the efficacy and safety of ruxolitinib cream in adolescents and adults with atopic dermatitis (AD).

Clinical Study Identifier: NCT03745638

Find a site near you

Start Over

Elite Clinical Studies

Phoenix, AZ United States
  Connect »

First OC Dermatology

Fountain Valley, CA United States
  Connect »

Dermatology Research Associates

Los Angeles, CA United States
  Connect »

Dermatology Specialists Inc

Oceanside, CA United States
  Connect »

Stanford University

Palo Alto, CA United States
  Connect »

Integrated Research Group Inc.

Riverside, CA United States
  Connect »

Advanced Rx Clinical Research

Westminster, CA United States
  Connect »

AdvancedPharma CR LLC

Miami, FL United States
  Connect »

Metabolic Research Institute Inc

West Palm Beach, FL United States
  Connect »

DS Research

New Albany, IN United States
  Connect »

DermAssociates

Rockville, MD United States
  Connect »

JDR Dermatology Research

Las Vegas, NV United States
  Connect »

Forest Hills Dermatology Group

Forest Hills, NY United States
  Connect »

Sadick Dermatology

New York, NY United States
  Connect »

Central Sooner Research

Norman, OK United States
  Connect »

Jordan Valley Medical Center

West Jordan, UT United States
  Connect »

West End Dermatology

Henrico, VA United States
  Connect »

York Dermatology Center

Richmond Hill, ON Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.